FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069339982> ?p ?o ?g. }

• W2069339982 endingPage "535" @default.
• W2069339982 startingPage "529" @default.
• W2069339982 abstract "OBJECTIVE In patients with hypothyroid goitrous Hashimoto's thyroiditis, the recovery from hypothyroidism seems to be due to a spontaneous decrease of antibodies (Ab) to the TSH-receptor (R). In contrast, in patients with Graves' disease made euthyroid by antithyroid drug therapy, the suppression of TSH secretion by thyroid hormone during antithyroid drug treatment decreases the production of Ab to TSH-R. We investigated in patients with initially euthyroid or hypothyroid goitrous Hashimoto's thyroiditis the relationships between thyroid status and the serum TSH-R, peroxidase (TPO) and thyroglobulin (Tg) Ab concentrations in untreated or l-thyroxine (T4) treated patients. PATIENTS A prospective study of 174 consecutive patients, referred with goitrous Hashimoto's disease in an initially euthyroid (group I, n= 78) or hypothyroid (group II, n= 96) state. The patients with positive (±=7%) TSH-RAb (group I, n = 18; group II, n = 22) were reinvestigated 12 months after the initiation of L-T4 therapy. After which, (1) L-T4 was continued and an evaluation performed 2 months later (i.e. 14 months after l-T4 initiation) in 9 patients of group I and in 11 patients of group II or (2) l-T4 was withdrawn and an evaluation performed 2 months later in 9 patients of group I and in 11 patients of group II. MEASUREMENTS Measurements of basal plasma TSH, free T4 (FT4) and total T3 and serum TSH-R, TPO and TgAb. RESULTS The prevalence of positive TSH-RAb levels did not differ between group I (23.1%) and group II (22.9%). However, the mean TSH-RAb level in group I (9.4 ± 0.4%) was lower (P<0.01) than in group II (11.6 ± 0.5%). In the patients with positive TSH-R Ab, (1) the prevalences of positive TSH-RAb decreased (P<0.001) under l-T4 therapy (group I = 22.2%, group II = 21.2%) and increased again (P<0.01) 2 months after l-T4 cessation (group I = 77.7%, group II = 63.6%) to reach lower levels (group I, P<0.05; group II, P<0.01) than those obtained prior to l-T4 treatment. Statistical analysis of TSH levels through the course of the study confirmed these results. (2) In contrast to the variations of the mean TgAb values, the variations of the mean TPOAb levels in each group were in good agreement with those of TSH-RAb through the course of the study. (3) There were significant correlations between some parameters of thyroid status and both TSH-RAb (TSH, r= 0.43, P&lt 0.001; FT4, r=-0.35, P<001) and TPOAb (TSH, r= 0.42, P<0.001; FT4, r= -0.31, P<0.01) levels. In contrast, no correlations were found between thyroid status and TgAb values. CONCLUSIONS This study demonstrates that thyroid status can modulate thyroid autoimmunity expression, such as TSH-RAb and TPOAb, in patients with euthyroid or hypothyroid goitrous Hashimoto's thyroiditis. Similar results have been reported in patients with Graves' disease made euthyroid by the administration of thyroid hormone during antithyroid drug treatment." @default.
• W2069339982 created "2016-06-24" @default.
• W2069339982 creator A5000593802 @default.
• W2069339982 creator A5017769380 @default.
• W2069339982 creator A5027908621 @default.
• W2069339982 creator A5031494538 @default.
• W2069339982 creator A5065089023 @default.
• W2069339982 creator A5069147234 @default.
• W2069339982 creator A5081389089 @default.
• W2069339982 date "1994-04-01" @default.
• W2069339982 modified "2023-10-17" @default.
• W2069339982 title "Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis" @default.
• W2069339982 cites W1950554297 @default.
• W2069339982 cites W1964687442 @default.
• W2069339982 cites W1971412151 @default.
• W2069339982 cites W1975845078 @default.
• W2069339982 cites W1976718840 @default.
• W2069339982 cites W1980419238 @default.
• W2069339982 cites W1983008334 @default.
• W2069339982 cites W1986466209 @default.
• W2069339982 cites W1987237609 @default.
• W2069339982 cites W1996017316 @default.
• W2069339982 cites W1999559912 @default.
• W2069339982 cites W2002536265 @default.
• W2069339982 cites W2032026491 @default.
• W2069339982 cites W2039228561 @default.
• W2069339982 cites W2040187230 @default.
• W2069339982 cites W2041309119 @default.
• W2069339982 cites W2042585754 @default.
• W2069339982 cites W2050326987 @default.
• W2069339982 cites W2057133278 @default.
• W2069339982 cites W2059405237 @default.
• W2069339982 cites W2061883080 @default.
• W2069339982 cites W2064840919 @default.
• W2069339982 cites W2069033081 @default.
• W2069339982 cites W2069978630 @default.
• W2069339982 cites W2081124154 @default.
• W2069339982 cites W2082424837 @default.
• W2069339982 cites W2088664874 @default.
• W2069339982 cites W2092753353 @default.
• W2069339982 cites W2098576707 @default.
• W2069339982 cites W2128266208 @default.
• W2069339982 cites W2137367595 @default.
• W2069339982 cites W2163793417 @default.
• W2069339982 cites W2168180129 @default.
• W2069339982 cites W2168517373 @default.
• W2069339982 cites W2170033012 @default.
• W2069339982 doi "https://doi.org/10.1111/j.1365-2265.1994.tb02494.x" @default.
• W2069339982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8187321" @default.
• W2069339982 hasPublicationYear "1994" @default.
• W2069339982 type Work @default.
• W2069339982 sameAs 2069339982 @default.
• W2069339982 citedByCount "41" @default.
• W2069339982 countsByYear W20693399822012 @default.
• W2069339982 countsByYear W20693399822013 @default.
• W2069339982 countsByYear W20693399822015 @default.
• W2069339982 countsByYear W20693399822016 @default.
• W2069339982 countsByYear W20693399822017 @default.
• W2069339982 countsByYear W20693399822019 @default.
• W2069339982 countsByYear W20693399822020 @default.
• W2069339982 countsByYear W20693399822022 @default.
• W2069339982 crossrefType "journal-article" @default.
• W2069339982 hasAuthorship W2069339982A5000593802 @default.
• W2069339982 hasAuthorship W2069339982A5017769380 @default.
• W2069339982 hasAuthorship W2069339982A5027908621 @default.
• W2069339982 hasAuthorship W2069339982A5031494538 @default.
• W2069339982 hasAuthorship W2069339982A5065089023 @default.
• W2069339982 hasAuthorship W2069339982A5069147234 @default.
• W2069339982 hasAuthorship W2069339982A5081389089 @default.
• W2069339982 hasConcept C126322002 @default.
• W2069339982 hasConcept C134018914 @default.
• W2069339982 hasConcept C158479217 @default.
• W2069339982 hasConcept C180650514 @default.
• W2069339982 hasConcept C2777195454 @default.
• W2069339982 hasConcept C2778696486 @default.
• W2069339982 hasConcept C2778835679 @default.
• W2069339982 hasConcept C526584372 @default.
• W2069339982 hasConcept C71924100 @default.
• W2069339982 hasConceptScore W2069339982C126322002 @default.
• W2069339982 hasConceptScore W2069339982C134018914 @default.
• W2069339982 hasConceptScore W2069339982C158479217 @default.
• W2069339982 hasConceptScore W2069339982C180650514 @default.
• W2069339982 hasConceptScore W2069339982C2777195454 @default.
• W2069339982 hasConceptScore W2069339982C2778696486 @default.
• W2069339982 hasConceptScore W2069339982C2778835679 @default.
• W2069339982 hasConceptScore W2069339982C526584372 @default.
• W2069339982 hasConceptScore W2069339982C71924100 @default.
• W2069339982 hasIssue "4" @default.
• W2069339982 hasLocation W20693399821 @default.
• W2069339982 hasLocation W20693399822 @default.
• W2069339982 hasOpenAccess W2069339982 @default.
• W2069339982 hasPrimaryLocation W20693399821 @default.
• W2069339982 hasRelatedWork W1972113515 @default.
• W2069339982 hasRelatedWork W200177572 @default.
• W2069339982 hasRelatedWork W2011960454 @default.
• W2069339982 hasRelatedWork W2120311357 @default.
• W2069339982 hasRelatedWork W2159864835 @default.
• W2069339982 hasRelatedWork W2322571913 @default.

• next